GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
Song Lyu, Xue Zhang, Zhenzhen Tu, Haisheng Zhou, Xisong Ke, Yi Qu
Topics & Concepts
Gambogic acidNF-κBCancerPharmacologyG protein-coupled receptorCancer researchIn vivoChemistryDrug discoveryDrugInnate immune systemCancer cellNFKB1Signal transductionIn vitroImmune systemBiologyMedicineImmunologyBiochemistryInternal medicineGeneTranscription factorBiotechnologySphingolipid Metabolism and SignalingNatural Compound Pharmacology StudiesCarbohydrate Chemistry and Synthesis